Neuroleptics and mortality: A 50-year cycle. Invited commentary on . . . schizophrenia, neuroleptic medication and mortality

British Journal of Psychiatry

Volumn 188, Issue FEB., 2006, Pages 128-

  Healy, David ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT;

COMPULSION; DELIRIUM; EXTRAPYRAMIDAL SYMPTOM; HISTORY OF MEDICINE; HUMAN; MORTALITY; NOTE; PARANOIA; PSYCHOSIS; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; HUMANS; SCHIZOPHRENIA;

EID: 31644435346     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.105.018911     Document Type: Note

References (4)

1. Joukamaa, M., Heliövaara, M., Knekt, P. et al (2006) Schizophrenia, neuroleptic medication and mortality. British Journal of Psychiatry, 188, 122-127.
2. Lehmann, H. E. (1993) Before they called it psychopharmacology. Neuropsychopharmacology, 8, 291-303.
3. Lehmann, H. E. (1996) Psychopharmacotherapy. In The Psychoptormacologists, Vol. 1 (ed. D. Healy), pp. 159-186. London: Arnold.
4. Lehmann, H. E. & Hanrahan, G. E. (1954) Chlorpromazine, new inhibiting agent for psychomotor excitement and manic states. Archives of Neurology and Psychiatry, 71, 227-237.